Aarey Drugs & Pharmaceuticals Ltd - 524412 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Aarey Drugs & Pharmaceuticals reported multiple non-compliances with SEBI regulations. Key issues include non-disclosure of a 7.09% promoter share sale, 1 lakh unlisted equity shares, and concerns over the completeness of insider trading data.
May 30 2026 20:19:43
Aarey Drugs & Pharmaceuticals Ltd - 524412 - Statement Of Deviation & Variation
Aarey Drugs & Pharmaceuticals has confirmed no deviation in the utilization of funds raised through convertible warrants. This ensures that the Rs. 31.90 crore raised via preferential issue has been used as per the stated objectives.
May 30 2026 20:18:19
Aarey Drugs & Pharmaceuticals Ltd - 524412 - Board Meeting Intimation for Regarding Postponement And Re-Schedule Of Board Meeting
Aarey Drugs & Pharmaceuticals' board meeting to consider and approve audited financial results for the financial year ended March 31, 2026, originally scheduled for May 29, 2026, has been postponed and rescheduled to May 30, 2026, due to unavoidable circumstances.
May 29 2026 20:14:17
Aarey Drugs & Pharmaceuticals Ltd - 524412 - Board Meeting Intimation for Approving The Audited Financial Results For The Quarter And Year Ended March 31, 2026
Aarey Drugs & Pharmaceuticals board is scheduled to meet on May 29, 2026. The agenda includes considering and approving the audited financial results for Q4 FY26 and the full financial year ended March 31, 2026.
May 25 2026 11:21:11
Read More